Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty

Artificial Organs

Volumn 33, Issue 7, 2009, Pages 538-543

  Beraudi, Alina ^a   Stea, Susanna ^a   Cremonini, Sara ^a   Visentin, Manuela ^a   Toni, Aldo ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Hip arthroplasty; Interleukins; Periprosthetic osteolysis; Synovial fluid

Indexed keywords

BODY FLUIDS; COMPLEX NETWORKS; FRACTURE; HIP PROSTHESES; ORTHOPEDICS;

ASEPTIC LOOSENING; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH SENSITIVITY; HIP ARTHROPLASTIES; HIP IMPLANTS; IMPLANT LOOSENING; INTERLEUKIN; PERIPROSTHETIC OSTEOLYSIS; SYNOVIAL FLUID; TOTAL HIP ARTHROPLASTY;

ARTHROPLASTY;

INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MARKER;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COMPREHENSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIP ARTHROPLASTY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; OSTEOLYSIS; PREDICTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHESIS LOOSENING; SAMPLE; SURGICAL TECHNIQUE; SYNOVIAL FLUID; TOTAL HIP PROSTHESIS;

EID: 67650838435     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00736.x     Document Type: Article

References (23)

1. Register of the Orthopaedic Prosthetic Implants R.I.P.O. Annual Report 2006. Available at:. Accessed February 22, 2008.
2. Goldring SR, Clark CR, Wright TM. The problem in total joint arthroplasty: aseptic loosening. J Bone Joint Surg Am 1993 75 : 799 801. (Pubitemid 23206693)
3. Gallo J, Raska M, Mrazek F. Bone remodelling, particle disease and individual susceptibility to periprosthetic osteolysis. Physiol Res 2007 Epub ahead of print WH. Osteolysis and particle disease in hip replacement. A review. Acta Orthop Scand 1994 65 : 113 23.
4. Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP. The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res 2007 454 : 251 61.
5. Sundfeldt M, Carlsson LV, Johansson CB, Thomsen P, Gretzer C. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop 2006 77 : 177 97.
6. Boyce BF, Schwarz EM, Xing L. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease. Curr Opin Rheumatol 2006 18 : 427 32.
7. Stains JP, Civitelli R. Cell-to-cell interactions in bone. Biochem Biophys Res Commun 2005 328 : 721 7.
8. Yeung JJ, Kim HJ, Abbruzzese TA, et al. Aortoiliac hemodynamic and morphologic adaptation to chronic spinal cord injury. J Vasc Surg 2006 44 : 1254 65.
9. Martin TJ, Sims NA. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 2005 11 : 76 81. (Pubitemid 40193486)
10. Kitamura H, Kawata H, Takahashi F, Higuchi Y, Furuichi T, Ohkawa H. Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow. Am J Pathol 1995 147 : 1682 92.
11. Motomura T, Kasayama S, Takagi M, et al. Increased interleukin-6 production in mouse osteoblastic MC3T3-E1 cells expressing activating mutant of the stimulatory G protein. J Bone Miner Res 1998 13 : 1084 91.
12. Ambruzova Z, Gallo J, Mrazek F, Kubistova Z, Onderkova J, Petrek M. Association of cytokine gene polymorphisms with the expansive periprosthetic osteolysis in total hip arthroplasty. Tissue Antigens 2006 67 : 178.
13. Fritz EA, Glant TT, Vermes C, Jacobs JJ, Roebuck KA. Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris. J Biomed Mater Res A 2006 77 : 192 201.
14. Wong N, Trindade MC, Patel R, Yaszay B, Goodman SB, Smith RL. Effects of interleukin-10 on titanium particle-induced macrophage transcription factor activation and cytokine expression in vitro. J Biomed Mater Res A 2004 69 : 40 6.
15. Goodman S, Trindade M, Ma T, et al. Modulation of bone ingrowth and tissue differentiation by local infusion of interleukin-10 in the presence of ultra-high molecular weight polyethylene (UHMWPE) wear particles. J Biomed Mater Res A 2003 65 : 43 50. (Pubitemid 37517284)
16. Toni A, Traina F, Stea S, et al. Early diagnosis of ceramic liner fracture. Guidelines based on a twelve-year clinical experience. J Bone Joint Surg Am 2006 88 (Suppl 4 55 63. (Pubitemid 44901974)
17. Heper Y, Akalin EH, Mistik R, et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 2006 25 : 481 91.
18. Gallina G, Dolcetti L, Serafini P, et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006 116 : 2777 90.
19. Muehlstedt SG, Lyte M, Rodriguez JL. Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia. Shock 2002 17 : 443 50.
20. Schoenbein C, Docke WD, Wolk K, et al. Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type. Clin Exp Immunol 2008 151 : 306 16.
21. Hedbom E, Hauselmann HJ. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002 59 : 45 53. (Pubitemid 34117355)
22. Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000 43 : 1916 26.
23. Ulfgren AK, Grondal L, Lindblad S, et al. Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment. Ann Rheum Dis 2000 59 : 439 47.